Series B equity round led by new investors to expand US commercialization, including growing the sales team.
- Amount
- $50M
- Stage
- Series B
- Announced
- 30 December 2025
- Lead
- Ally Bridge Group
- Other investors
- OrbiMed Advisors, Elevage Medical Technologies
- Use of funds
- Series B equity round led by new investors to expand US commercialization, including growing the sales team.
- Checked
- Announced by the company